price
NA
NASDAQ · NAGE
Niagen Bioscience Inc
Healthcare · Biotechnology
$2.69
Up+$0.03 (+1.12%)
Updated Oct 8, 2026, 12:33 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 529.91M
- P/E ratio
- 29.68
- Dividend yield
- 0.00%
- 52-week range
- $2.61 – $5.40
- Volume
- 373.38K
- Avg. volume
- 1.04M
Price performance · NAGE
NAGE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
NAGE closed at $2.69 after 20 trading sessions, down 11.80% for the selected period.
- Last close
- $2.69
- Period change
- -11.80%
- Period low
- $2.68
- Period high
- $3.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.67 | $2.705 | $2.66 | $2.69 | 373.38K |
| Oct 5, 2026 | $2.79 | $2.79 | $2.665 | $2.68 | 865.14K |
| Oct 2, 2026 | $2.72 | $2.80 | $2.61 | $2.79 | 1.57M |
| Oct 1, 2026 | $2.91 | $2.92 | $2.67 | $2.68 | 1.39M |
| Sep 30, 2026 | $2.97 | $2.98 | $2.91 | $2.92 | 360.54K |
| Sep 29, 2026 | $3.00 | $3.00 | $2.95 | $2.95 | 279.14K |
| Sep 28, 2026 | $3.04 | $3.07 | $2.94 | $2.98 | 411.44K |
| Sep 25, 2026 | $3.02 | $3.06 | $2.98 | $3.05 | 619K |
| Sep 24, 2026 | $2.99 | $3.04 | $2.98 | $3.01 | 382.36K |
| Sep 23, 2026 | $3.08 | $3.09 | $2.995 | $3.00 | 390.9K |
| Sep 22, 2026 | $3.08 | $3.12 | $3.0414 | $3.09 | 478.84K |
| Sep 21, 2026 | $2.99 | $3.04 | $2.965 | $3.04 | 292.62K |
| Sep 18, 2026 | $2.99 | $3.025 | $2.9701 | $2.99 | 609.17K |
| Sep 17, 2026 | $2.99 | $3.035 | $2.9802 | $2.99 | 217.3K |
| Sep 16, 2026 | $3.01 | $3.05 | $2.98 | $3.00 | 340.24K |
| Sep 15, 2026 | $3.04 | $3.04 | $2.945 | $3.00 | 573.55K |
| Sep 14, 2026 | $3.035 | $3.10 | $3.03 | $3.04 | 420.76K |
| Sep 11, 2026 | $3.08 | $3.085 | $3.01 | $3.04 | 322.14K |
| Sep 10, 2026 | $3.03 | $3.065 | $3.00 | $3.035 | 276.57K |
| Sep 9, 2026 | $3.105 | $3.105 | $3.03 | $3.05 | 362.02K |
Latest NAGE news
The latest Smart Investors Daily articles mentioning NAGE.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

